中国免疫学杂志
中國免疫學雜誌
중국면역학잡지
CHINESE JOURNAL OF IMMUNOLOGY
2014年
5期
633-638
,共6页
付静静%盛康亮%李影%李培培%汪庆童%陈镜宇%吴华勋%张玲玲%魏伟
付靜靜%盛康亮%李影%李培培%汪慶童%陳鏡宇%吳華勛%張玲玲%魏偉
부정정%성강량%리영%리배배%왕경동%진경우%오화훈%장령령%위위
耐受性树突细胞%骨髓源%分离%功能鉴定
耐受性樹突細胞%骨髓源%分離%功能鑒定
내수성수돌세포%골수원%분리%공능감정
Tolerogenic dendritic cells%Bone marrow-derived%Isolation%Functional identification
目的:建立小鼠骨髓源耐受性树突状细胞(CD11b+F4/80+TDCs)体外培养及功能鉴定方法。方法:以重组小鼠粒细胞-巨噬细胞集落刺激因子( rmGM-CSF )和重组白介素4( rmIL-4)体外诱导小鼠骨髓细胞分化为未成熟树突细胞(iDCs),收集第六天的细胞采用流式细胞术分离纯化CD11b+F4/80+TDCs。倒置显微镜动态观察细胞形态学变化,流式细胞术观察并分选CD11b+F4/80+TDCs,CD11b+F4/80+TDCs的耐受功能通过MHCⅡ类分子、CD83、IDO、TLR-2的表达及IL-10和TGF-β1细胞因子的产生进行评价。流式细胞术测定MHCⅡ类分子表达,免疫组化法测定CD83、IDO、TLR-2的表达,ELISA法测定IL-10和TGF-β1的水平,同时设LPS刺激诱导的成熟树突细胞(mDCs)作对照。结果:镜下可见新鲜分离的骨髓细胞呈圆形,体积小,2 d后,部分细胞形态发生改变,体积增大,细胞聚集成团,培养5~6 d,细胞集落增多,形态不规则。同时表面出现较多毛刺样突起。 CD11b+F4/80+TDCs 含量在23%左右,经流式分选后细胞纯度达到99%以上。与 mDCs 比较, CD11b+F4/80+TDCs低表达MHCⅡ和CD83,高表达IDO、TLR-2,并分泌IL-10和TGF-β1。结论:用小鼠rmGM-CSF和rmIL-4体外能成功诱导小鼠骨髓源CD11b+F4/80+TDCs,并且CD11b+F4/80+TDCs通过表达IL-10、TGF-β1、IDO和TLR-2显示耐受功能。
目的:建立小鼠骨髓源耐受性樹突狀細胞(CD11b+F4/80+TDCs)體外培養及功能鑒定方法。方法:以重組小鼠粒細胞-巨噬細胞集落刺激因子( rmGM-CSF )和重組白介素4( rmIL-4)體外誘導小鼠骨髓細胞分化為未成熟樹突細胞(iDCs),收集第六天的細胞採用流式細胞術分離純化CD11b+F4/80+TDCs。倒置顯微鏡動態觀察細胞形態學變化,流式細胞術觀察併分選CD11b+F4/80+TDCs,CD11b+F4/80+TDCs的耐受功能通過MHCⅡ類分子、CD83、IDO、TLR-2的錶達及IL-10和TGF-β1細胞因子的產生進行評價。流式細胞術測定MHCⅡ類分子錶達,免疫組化法測定CD83、IDO、TLR-2的錶達,ELISA法測定IL-10和TGF-β1的水平,同時設LPS刺激誘導的成熟樹突細胞(mDCs)作對照。結果:鏡下可見新鮮分離的骨髓細胞呈圓形,體積小,2 d後,部分細胞形態髮生改變,體積增大,細胞聚集成糰,培養5~6 d,細胞集落增多,形態不規則。同時錶麵齣現較多毛刺樣突起。 CD11b+F4/80+TDCs 含量在23%左右,經流式分選後細胞純度達到99%以上。與 mDCs 比較, CD11b+F4/80+TDCs低錶達MHCⅡ和CD83,高錶達IDO、TLR-2,併分泌IL-10和TGF-β1。結論:用小鼠rmGM-CSF和rmIL-4體外能成功誘導小鼠骨髓源CD11b+F4/80+TDCs,併且CD11b+F4/80+TDCs通過錶達IL-10、TGF-β1、IDO和TLR-2顯示耐受功能。
목적:건립소서골수원내수성수돌상세포(CD11b+F4/80+TDCs)체외배양급공능감정방법。방법:이중조소서립세포-거서세포집락자격인자( rmGM-CSF )화중조백개소4( rmIL-4)체외유도소서골수세포분화위미성숙수돌세포(iDCs),수집제륙천적세포채용류식세포술분리순화CD11b+F4/80+TDCs。도치현미경동태관찰세포형태학변화,류식세포술관찰병분선CD11b+F4/80+TDCs,CD11b+F4/80+TDCs적내수공능통과MHCⅡ류분자、CD83、IDO、TLR-2적표체급IL-10화TGF-β1세포인자적산생진행평개。류식세포술측정MHCⅡ류분자표체,면역조화법측정CD83、IDO、TLR-2적표체,ELISA법측정IL-10화TGF-β1적수평,동시설LPS자격유도적성숙수돌세포(mDCs)작대조。결과:경하가견신선분리적골수세포정원형,체적소,2 d후,부분세포형태발생개변,체적증대,세포취집성단,배양5~6 d,세포집락증다,형태불규칙。동시표면출현교다모자양돌기。 CD11b+F4/80+TDCs 함량재23%좌우,경류식분선후세포순도체도99%이상。여 mDCs 비교, CD11b+F4/80+TDCs저표체MHCⅡ화CD83,고표체IDO、TLR-2,병분비IL-10화TGF-β1。결론:용소서rmGM-CSF화rmIL-4체외능성공유도소서골수원CD11b+F4/80+TDCs,병차CD11b+F4/80+TDCs통과표체IL-10、TGF-β1、IDO화TLR-2현시내수공능。
Objective:To establish the methods of isolated culture and functional identification of mice bone marrow derived tolerogenic dendritic cells (CD11b+F4/80 +TDCs) in vitro.Methods: Mice bone marrow cells were isolated and cultured to obtain iDCs with the simulation of mouse rmGM-CSF and rmIL-4.CD11b+F4/80 +TDCs were purified by fluorescence-activated cell sorting on day 6.The morphological changes of TDCs were observed with the inverted microscope dynamically .The expression of CD11b+F4/80 +TDCs were analyzed by the flow cytometry .Tolerogenic function of CD11b+F4/80 +TDCs was evaluated by the expression of MHCⅡ, CD83, IDO, TLR-2, IL-10 and TGF-β1.The expression of MHCⅡ was analyzed by the flow cytometry , and the expression of CD83, IDO and TLR-2 were analyzed by immune-histochemistry.The levels of IL-10 and TGF-β1 in the supernatant of CD11b+F4/80 +TDC were analyzed by ELISA .Meanwhile mature DCs ( mDCs) induced by LPS were used as control .Results:The fresh isolated bone marrow cells look like round and small under microscope .After two days of culture , cells became big and formed into clusters . Five or six days later, cells clusters increased, and the morphology of cells became irregular .At the same time, more dendrite ap-peared on the surface of cells .The percentage of CD11b+F4/80 +TDCs induced by rmGM-CSF and rmIL-4 was about 23%, and the purity of the purified BM CD11b+F4/80 +iDC was about 99%.Compared with mDCs, CD11b+F4/80 +TDCs expressed low levels of MHCⅡand CD83 and high levels of IDO, TLR-2, IL-10 and TGF-β1.Conclusion:CD11b+F4/80 +TDCs derived from mouse bone marrow could be induced successfully by rmGM-CSF and rmIL-4 in vitro.CD11b+F4/80 +TDCs showed tolerogenic function by the expressions of IL-10, TGF-β1, IDO and TLR-2.